Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2 by Silva, Mariana Soares da et al.
Rev Inst Med Trop São Paulo. 2021;63:e58 Page 1 of 8
BRIEF COMMUNICATION
http://doi.org/10.1590/S1678-9946202163058
This is an open-access article distributed under the 
terms of the Creative Commons Attribution License.
¹Universidade Feevale, Laboratório de 
Microbiologia Molecular, Novo Hamburgo, 
Rio Grande do Sul, Brazil.
²Secretaria Municipal da Saúde, Campo 
Bom, Rio Grande do Sul, Brazil.
Correspondence to: Mariana Soares da 
Silva  
Universidade Feevale, Laboratório de 
Microbiologia Molecular, Rodovia ERS-239, 
Nº 2755, Prédio Vermelho, Piso 1, sala 103, 
Vila Nova, CEP 93525-075,  
Novo Hamburgo, RS, Brazil
E-mail: marisoares.vet@gmail.com
Received: 18 June 2021
Accepted: 23 June 2021
Early detection of SARS-CoV-2 P.1 variant in Southern Brazil 
and reinfection of the same patient by P.2 
Mariana Soares da Silva ¹, Meriane Demoliner¹, Alana Witt Hansen¹, Juliana 
Schons Gularte¹, Flávio Silveira¹, Fágner Henrique Heldt¹, Micheli Filippi¹, 
Vyctoria Malayhka de Abreu Góes Pereira¹, Francini Pereira da Silva¹, Larissa 
Mallmann¹, Pietra Fink¹, Luana Letícia da Silva², Matheus Nunes Weber¹, 
Paula Rodrigues de Almeida¹, Juliane Deise Fleck¹, Fernando Rosado Spilki¹
ABSTRACT
Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus 
(SARS‑CoV‑2) have been constantly reported across the world. The B.1.1.28 lineage has 
been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), 
recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a 
variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern 
Brazil in late November 2020, soon after the emergence of the variant in Manaus, Northern 
Brazil. The same male patient was reinfected by another B.1.1.28 variant, namely P.2, in 
March, 2021. The genomic analysis confirmed genetically significant differences between 
the two viruses recovered in both infections, the P.1 lineage in the first episode and P.2 in the 
reinfection. Due the very early detection of P.1, we have also investigated the circulation of 
P.1 in the same region by differential RT‑qPCR, showing that this was an isolated case of P.1 
at the time of detection, and this variant has disseminated and became prominent from late 
January to the end of March, 2021. SARS‑CoV‑2 recent reports of reinfection have raised 
critical questions on whether and how well a first infection protects against reinfection.
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INTRODUCTION
The emergence of the novel SARS‑CoV‑2 lineages is currently a worldwide 
concern. The continuous rise of variants is probably related to an increased rate of 
virus transmission and evasion from the host’s immune system. Lately, research 
groups have reported the emergence of multiple variants of concern (VOC) or of 
interest (VOI), such as P.11, P.22, N.93 and B.1.3514 in specific Brazilian regions. 
P.1 (VOC), recently named as Gamma variant by the newly WHO nomenclature 
proposal5 as well as P.2 (VOI) variants have evolved from the lineage B.1.1.281,2 
and harbor E484K (P.1 and P.2) and N501Y (P.1) mutations, which are associated 
with increased transmissibility or immune evasion6. The persistence of protective 
immunity provided by the coronavirus disease 2019 (COVID‑19) or vaccination is 
not yet well established and some cases of reinfection have been reported7,8. 
The B.1.1.28 SARS‑CoV‑2 lineage has been circulating in Brazil since February 
2020; P.2 (alias for B.1.1.28.2) was first detected in Rio de Janeiro2 harboring the 
mutation S:E484K, and P.1 (alias of B.1.1.28.1) was first detected in Japanese 
travelers returning from the Amazonas State and due to the presence of several 
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important mutations in the receptor binding domain ‑ 
RBD of the viral spike (K417T, E484K, and N501Y) is of 
particular concern in Brazil. The P.1 variant is widely spread 
in the country, being associated with local outbreaks of great 
magnitude due to an enhanced transmissibility. The P.1 
lineage more likely appeared in Manaus, Northern Brazil9 
in mid‑November, even though, recent studies have shown 
an earlier possible origin for a P.1 ancestral in mid‑August 
2020 and for the common P.1 variant in mid‑October10. The 
first described cases attributed to P.1 in Southern Brazil so 
far are from the last week of January 2021.
In this study, we report a case of SARS‑CoV‑2 P.1 
infection in a 39‑year‑old individual from Campo Bom city 
(latitude 29º40’44” South and at longitude 51º03’10” West), 
Rio Grande do Sul State the Southernmost State of Brazil, 
in late November 2020. The same patient acquired a second 
infection by another variant, the P.2 lineage, in March 
2021. Due the very early detection of P.1, we also have 
investigated the circulation of P.1 in the same geographic 
region using a differential VOC RT‑qPCR. The study was 
carried out from the time of the first infection (November 
2020) to April 2021, since P.1 emerged in Northern Brazil 
in mid‑November11 and the first cases described in Southern 
Brazil occurred in late January 2021.
MATERIAL AND METHODS
RT-qPCR for SARS-CoV2 detection 
Naso‑oropharyngeal swab samples from the same patient 
(LMM38991 and LMM50731) were received at Laboratorio 
de Microbiologia Molecular of Universidade Feevale, Novo 
Hamburgo, Rio Grande do Sul State, Brazil, (November 30th, 
2020 and March 11th, 2021) for SARS‑CoV‑2 detection. Total 
nucleic acid was extracted with the commercial MagMAX™ 
CORE Nucleic Acid Purification Kit (Applied biosystems™, 
Thermo Fisher Scientific, Waltham, MA, USA) kit, using the 
automated equipment KingFisher™ Duo Prime (Thermo 
Fisher Scientific™). RT‑qPCR for SARS‑CoV‑2 cDNA 
detection targeting the viral E gene was performed according 
to the Charité Institute, Berlin, Germany, protocols12 and was 
carried out using AgPath‑ID One‑Step RT‑PCR Reagents 
(Thermo Fisher Scientific™). 
Differential RT-qPCR
A differential RT‑qPCR for the P1 lineage9 that detects 
the ORF 1b deletion (NSP6: S106 del, G107 del, F108 del) 
was performed. This deletion is a genetic signature of the 
VOCs P.1, B.1.1.7and B.1.351. The differential RT‑qPCR 
was carried out using AgPath‑ID One‑Step RT‑PCR 
Reagents (Thermo Fisher Scientific™); primers and probes 
were used following the same protocol as described by 
Naveca et al.9. A total of 302 samples was tested (Ct values 
for the E gene ranging between 10 and 20) randomly 
distributed over 22 weeks that started on November 2nd, 
2020 until April 4th, 2021. New SARS‑CoV‑2 cases, 
hospitalizations and deaths in the neighboring regions were 
compared with the P.1 lineage study results. This study was 
approved by the National Committee of Research Ethics and 
the Institutional Ethical Review Board of the Universidade 
Feevale (protocol Nº 33202820.7.1001.5348), following 
Brazilian regulations and international ethical standards.
Viral Whole Genome Sequencing and Phylogenetic 
Analysis
RNA was extracted from naso‑oropharyngeal swab 
samples and reverse transcription reaction was performed 
using the SuperScript IV reverse transcriptase kit (Thermo 
Fisher Scientific, Waltham, MA, USA). Preparation of the 
whole viral genome library was performed using the QIAseq 
SARS‑CoV‑2 Primer Panel paired for library enrichment 
and QIAseq FX DNA Library UDI Kit, according to the 
manufacturer instructions (QIAGEN, Hilden, Germany). 
Sequencing was implemented in an Illumina MiSeq platform 
using MiSeq Reagent Kit v3 (600‑cycle) from Illumina Inc. 
(Foster city, CA, USA). All procedures were conducted in 
a laminar flow to minimize the risk of contamination. The 
FASTQ reads were imported to Geneious Prime, trimmed 
(BBDuk 37.25), and mapped against the reference sequence 
hCoV‑19/Wuhan/WIV04/2019 (EPI_ISL_402124) available 
in the EpiCoV database from GISAID13.
A total of 97 Brazilian SARS‑CoV‑2 complete genomes 
and the reference sequence (EPI_ISL_402124) (>29 kb) 
were retrieved from the GISAID database and aligned 
with the sequences generated herein. Sequence alignment 
was performed using the Clustal Omega software and 
the reference sequence from Wuhan was applied as the 
outgroup. The Maximum Likelihood phylogenetic analysis 
under the General Time Reversible model, allowing for a 
proportion of invariable sites and substitution rates were 
inferred empirically in IQ‑TREE v2.1.2 web server14 
especially for maximum‑likelihood (ML, applying 200 
replicates and 1,000 bootstraps.
RESULTS
Case description and epidemiological findings
A 39‑years‑old male patient, presenting with 
comorbidities (chronic cardiovascular disease and diabetes 
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mellitus) reported two clinical episodes of COVID‑19. 
The first one was on November 30th, 2020, and the second 
one on March 11th, 2021. During the first infection period, 
the patient’s symptomatology was not reported. However, 
the patient claimed to have had contact with his brother, 
who had previously tested positive for SARS‑CoV‑2. He 
had also visited his SARS‑CoV‑2 infected father at the 
hospital in a room shared with other COVID‑19 diagnosed 
patients and, despite the efforts, it was not possible to know 
if the patient has had previous contact with any traveler 
from Manaus, since the region is highly known for trade 
and tourism. In the second infectious episode, the patient 
experienced dyspnea, fatigue and respiratory distress and 
an oxygen saturation < 95% as a clinical sign. The second 
infection evolved with complications, and the patient was 
admitted to an Intensive Care Unit (ICU) and intubated 
due to a severe loss of pulmonary capacity. The patient 
unfortunately died on March 19th, 2021, 12 days after the 
onset of symptoms. 
Diagnostic laboratory findings
Both diagnostic RT‑qPCR assays were positive, 
presenting a Ct value of 30.07 (LMM38991) and 18.83 
(LMM50731). The differential RT‑qPCR retrospective 
study resulted in 226 negative samples and 122 positive 
samples for the P.1 variant. Except for the reinfected patient 
(who was not analyzed according to the CT value), the 
circulation of P.1 in Rio Grande do Sul State was evidenced 
in our sampling from January 27th, 2021 on (Figure 1A). 
Furthermore, the peak of P.1 lineage detections coincides 
with the peak of SARS‑CoV‑2 new cases (Figure 1B), 
hospitalizations (Figure 1C) and deaths (Figure 1D) in the 
neighboring region. 
Genome sequencing and bioinformatics analysis
Two high‑quality SARS‑CoV‑2 whole‑genome 
sequences, named LMM38991/2020 and LMM50731/2021 
Figure 1 - Emergence of SARS-CoV-2 P.1 lineage and general situation of COVID-19: (A) Retrospective analysis based on differential 
RT-qPCR: The gray bars represent the negative results predominating during the first epidemiological weeks. Afterwards, positive 
samples (represented by pink bars) replaced the parental lineages; (B) COVID-19 new cases; (C) COVID-19 hospitalizations and 
(D) COVID-19 deaths. 
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(EPI_ISL_1630158 and EPI_ISL_1629809) were recovered 
from the same patient, corresponding to the first infection 
and the reinfection, respectively. Consensus sequences 
LMM38991/2020 and LMM50731/2021 presented a 
mean coverage of 1,405x and 1,263x. The sequences 
were first classified using the Pangolin COVID‑19 
Lineage Assigner tool15 indicating the presence of two 
discordant SARS‑CoV‑2 lineages: the P.1 lineage in 
the primo‑infection (LMM38991/2020; Gisaid access 
EPI_ISL_ EPI_ISL_1630158) and the P.2 lineage 
(LMM50731/2021; Gisaid access EPI_ISL_1629809) in 
reinfection. 
The phylogenetic analysis confirmed previous results. 
LMM38991/2020 was clearly clustered with the P.1 
lineage, while LMM50731/2021 branched out into P.2 
group (Figure 2). LMM38991/2020 and LMM50731/2021 
displayed the typical P.1 and P.2 spike protein E484K 
mutations and INDELs. LMM38991/2020, presented all 
11 typical P.1 amino acid non‑synonymous changes in the 
S protein (L18F, T20N, P26S, D138Y, R190S, K417T, 
E484K, N501Y, D614G, H655Y, T1027I, V1176F) and 
LMM50731/2021 presented three previously reported 
amino acid changes in S protein (E484K, D614G, V1176F) 
of the P.2 lineage.
DISCUSSION AND CONCLUSIONS
This study described a COVID‑19 primo‑infection 
caused by a P.1 lineage followed by a reinfection by a P.2 
lineage in a three‑month interval. A male, 39‑years‑old 
patient with history of comorbidities, presented two 
clinical episodes of COVID‑19. Few reinfection cases were 
described worldwide, especially with detection of different 
SARS‑CoV‑2 lineages16. In addition, there are apparently 
more cases reporting asymptomatic/mild disease during 
reinfection episodes17, although some cases showed a more 
severe illness in the second episode16,18 as the one described 
here. These evidences are reinforced by the apparent low 
viral quantification determined by RT‑qPCR in the primo‑
infection. 
Viral immune evasion or limited and transitory 
protective immunity might be the cause of this reinfection 
as observed in the last cases to date7, especially emerging 
lineages reinfections (P.1 and P.2) that might also reflect the 
ability of S:K484 virus to escape from anti‑SARS‑CoV‑2 
neutralizing antibodies. Although P.1 and P.2 variants have 
been related to antibody evasion in patients previously 
immunized by non‑mutated lineages6 in the case described 
herein, the patient may have produced antibodies that 
included the S:484K site, but apparently these antibodies 
did not prevent a second infection by the P.2 lineage.
Figure 2 - Phylogenetic tree of SARS-CoV-2 complete genomes. 
The Maximum Likelihood phylogenetic analysis under the 
General Time Reversible allowing for a proportion of invariable 
sites, with empirical rates and substitution rates empirically 
inferred in the IQ-TREE (v2.1.2 web server applying 200 
replicates and 1,000 bootstraps).
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The P.1 lineage has most probably emerged in Brazil 
in middle November 2020 in Manaus, Northern region9,11. 
However, recent studies have shown an earlier possible 
origin for an ancestral P.1 in mid‑August 2020 and for 
the nowadays common P.1 variant in mid‑October10. 
Our findings showed that the P.1 lineage was present in 
Southern Brazil soon after, in late November. Later, other 
early detections of the P.1 lineage were described in other 
Brazilian States, such as Bahia, Salvador city19. 
According to our retrospective analysis, based on 
differential qRT‑PCR, it is important to note that despite 
the case reported herein, the P.1 lineage did not spread in 
a first moment, as observed in other Brazilian cities and 
also in other countries. In Argentina, the first P.1 case was 
reported on February 8th, 2021, but the variant consistently 
spread between March and April, 202120. Expressive 
number of positive P.1 cases were found only at the end 
of January in Southern Brazil, that replaced the parental 
lineages thereafter. 
In summary, this study reported and characterized 
an early primary COVID‑19 caused by the P.1 lineage 
followed by a reinfection episode, in Southern, Brazil 
some months later. The P.1 lineage is spreading rapidly 
across Brazil21 and after its establishment, has been 
related to an exponential increment of transmissibility 
and hospitalization rates11 as observed in our data. It is 
important to understand the new lineages origin, but since 
the patient made several personal contacts, including 
some with close family members that were also infected 
with SARS‑CoV‑2, there was a higher risk of infection. 
Despite our efforts, due the high number of infected 
contacts that our patient had prior to and during the first 
infection, it was impossible to establish the source of 
infection. Nevertheless, reinfection studies are essential 
to understand whether these are isolated or widely 
distributed cases17. These cases have attracted considerable 
attention since they indicate that SARS‑CoV‑2 infections 
do not uniformly confer protective immunity for infected 
individuals.
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